Chemed (CHE)
(Delayed Data from NYSE)
$517.44 USD
-5.72 (-1.09%)
Updated Dec 23, 2024 04:00 PM ET
After-Market: $517.39 -0.05 (-0.01%) 7:00 PM ET
4-Sell of 5 4
C Value D Growth B Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CHE 517.44 -5.72(-1.09%)
Will CHE be a Portfolio Killer in December?
Zacks Investment Research is releasing its prediction for CHE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CHE
EHC or CHE: Which Is the Better Value Stock Right Now?
Amedisys (AMED) Down 12.4% Since Last Earnings Report: Can It Rebound?
CHE: What are Zacks experts saying now?
Zacks Private Portfolio Services
EHC vs. CHE: Which Stock Is the Better Value Option?
Chemed Stock Hurt by Roto-Rooter Softness, Macro Issues Dent Growth
AMED or CHE: Which Is the Better Value Stock Right Now?
Other News for CHE
(CHE) - Analyzing Chemed's Short Interest
$100 Invested In Chemed 10 Years Ago Would Be Worth This Much Today
China CITIC Announces Key Financial Meeting for 2024
Columbia Small Cap Growth Fund Q3 2024 Commentary
Wells Fargo’s ‘SMID-cap’ List: TKO, BRBR, CPAY, and more!